Paclitaxel
- Product NDC
- 70860-200
- 11-digit product format
- 708600200
- Labeler code
- 70860
- Product ID
- 70860-200_235721cb-397d-4e44-8299-4373cd9d2497
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- paclitaxel
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA207326
- Marketing category
- ANDA
- Marketing start
- 2017-03-24
- Marketing end
- 0000-00-00
- Substance
- PACLITAXEL
- Active strength
- 6 mg/mL
- Pharmacologic classes
- Microtubule Inhibition [PE],Microtubule Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-200-05 | 70860020005 | 1 VIAL in 1 CARTON (70860-200-05) > 5 mL in 1 VIAL | 1 vial | 2017-03-24 | 0000-00-00 | No | No | Current |
| 70860-200-17 | 70860020017 | 1 VIAL in 1 CARTON (70860-200-17) > 16.7 mL in 1 VIAL | 1 vial | 2017-03-24 | 0000-00-00 | No | No | Current |
| 70860-200-50 | 70860020050 | 1 VIAL in 1 CARTON (70860-200-50) > 50 mL in 1 VIAL | 1 vial | 2017-03-24 | 0000-00-00 | No | No | Current |